Investigational Site Number 4 — Oklahoma City, Oklahoma

Investigational Site Number 4 is a clinical research site located in Oklahoma City, Oklahoma, United States 73104.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Site Number 4 has participated in 1 clinical trials.

Therapeutic areas: Tumor Lysis Syndrome.

Sponsors: Sanofi.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 4?

Investigational Site Number 4 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 4 conducted?

Investigational Site Number 4 has 1 clinical trials on record. Their work covers Tumor Lysis Syndrome.

Is Investigational Site Number 4 accredited by Crixeo Health?

Investigational Site Number 4 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 4?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.